Skip to main content

News

Nuvoton Cuts EIS Battery-Monitoring Heat by 93% with New Chip

Kyoto – September 29, 2026 -- Nuvoton Technology Corporation Japan (NTCJ) will begin sampling its KA85010UA battery monitoring IC in January 2027, a 26-cell chip that integrates electrochemical impedance spectroscopy (EIS) directly on-chip while cutting PCB temperature rise during measurements by approximately 93% compared with conventional methods.

Inductor-based design slashes power loss and heat by 93%

The KA85010UA replaces the industry-standard resistor method with NTCJ's proprietary inductor approach for EIS measurement, reducing both energy loss and PCB temperature rise by roughly 93%, according to company evaluations. The lower thermal footprint allows EIS functionality to be embedded directly into automotive batteries and energy storage systems without dedicated external measurement equipment.

Valmet to Pay EUR 0.67 Second Dividend Instalment on Oct 7

Espoo – September 29, 2026 -- Valmet Oyj's Board of Directors has confirmed that the second instalment of its 2025 dividend, EUR 0.67 per share, will be paid on October 7, 2026.

Shareholders on record October 1 qualify for payout

The dividend will go to shareholders registered in Valmet's shareholders' register held by Euroclear Finland Oy on the record date of October 1, 2026.

Total 2025 dividend reaches EUR 1.35 per share in two tranches

Valmet's Annual General Meeting in 2026 approved a total dividend of EUR 1.35 per share for the 2025 financial year, split into two instalments. The first tranche of EUR 0.68 per share was paid on April 9, 2026.

Payout ratio hits 89%, well above policy floor

Valmet's dividend policy commits to distributing at least 50% of the period's profit as dividend. The 2025 payout ratio stands at 89%, substantially exceeding that minimum threshold.

i2Cool Debuts Electricity-Free Cooling Fabrics for Umbrellas, Greenhouses

Image
i2Cool Debuts Electricity-Free Cooling Fabrics for Umbrellas, Greenhouses

Shenzhen, China – September 29, 2026 -- i2Cool has expanded its passive radiative cooling fabric line with two electricity-free products, i2Umbrella Fabric-Hyber and i2Tarpaulin, that lower surface temperatures without power or refrigerants.

New umbrella fabric cuts ambient temperature by 5.2°C without electricity

i2Umbrella Fabric-Hyber, engineered for umbrellas, patio shades and outdoor canopies, achieves solar reflectivity of up to 76% and mid-infrared emissivity of up to 96%. In controlled outdoor testing, the fabric produced internal temperatures 5.2°C cooler than unshaded areas and 2.4°C cooler than conventional silver-coated sun-protection fabrics. The material also blocks 99% of UV radiation and offers full blackout capability with high water repellency.

Implantica's RefluxStop Draws Overflow Crowd at U.S. Launch Event

Washington D.C. – September 29, 2026 -- Implantica AG launched its FDA-approved RefluxStop device in the U.S. market at the American Foregut Society (AFS) 2026 Annual Meeting, drawing an over-capacity crowd of more than 120 surgeons and gastroenterologists that forced organizers to turn away additional attendees.

FDA approval opens U.S. market for non-encircling GERD device

Following its recent Premarket Approval (PMA) from the U.S. Food and Drug Administration, RefluxStop entered a U.S. GERD treatment market estimated at 78 million patients. Unlike conventional anti-reflux surgeries that wrap around the esophagus, RefluxStop is designed to restore natural anatomy without encircling the food passageway, aiming to reduce side effects such as dysphagia and inability to belch or vomit.

Sectra Enters Brazil Market via Partnership with S&S Partners

Linköping – – September 29, 2026 -- Swedish medical imaging IT firm Sectra (STO: SECT B) has signed a partner agreement with S&S Partners to enter Brazil, Latin America's largest healthcare market, with an initial focus on its cloud-based enterprise imaging platform Sectra One Cloud.

Brazil's 7,100 hospitals drive shift from on-premise to cloud imaging

Brazil operates approximately 7,100 hospitals, with the private sector accounting for the majority of advanced imaging investment. Major private hospital groups are pushing the market away from on-premise capital purchases toward subscription-based cloud platforms, a shift Sectra says is already gaining momentum.

Torbjörn Kronander, President and CEO at Sectra, said the partnership with S&S Partners provides access to the relationships and local market knowledge required for entry into Brazil.

Lilly's Foundayo Outperforms Oral Semaglutide 25 mg in New Diabetes Data

Image
Lilly's Foundayo Outperforms Oral Semaglutide 25 mg in New Diabetes Data

Indianapolis – September 29, 2026 -- Eli Lilly and Company (NYSE: LLY) reported that its oral GLP-1 drug Foundayo (orforglipron) at 17.2 mg produced 1.5% greater weight loss and 0.3% greater A1C reduction than oral semaglutide 25 mg over 52 weeks in adults with type 2 diabetes, based on an indirect treatment comparison presented at the 62nd Annual Meeting of the European Association for the Study of Diabetes in Milan.

Indirect analysis draws on ACHIEVE-3 and PIONEER PLUS trial data

The comparison, covariate-adjusted for gender, age, baseline A1C and baseline weight, found weight-loss differences ranging from 1.5% to 2.4% and A1C reductions of 0.3% to 0.6% in favor of Foundayo 17.2 mg across multiple statistical methods. The 95% confidence interval for weight loss was -2.7% to -0.2%, and for A1C reduction was -0.6% to -0.1%.

Arthex Biotech Names Ex-IVERIC bio CEO Glenn Sblendorio Chairman

Image
Arthex Biotech Names Ex-IVERIC bio CEO Glenn Sblendorio Chairman

Valencia – – September 29, 2026 -- Arthex Biotech has appointed Glenn Sblendorio, former CEO of IVERIC bio, as Chairman of its Board of Directors as the clinical-stage RNA therapeutics company advances its lead program ATX-01 through Phase I/IIa trials for myotonic dystrophy type 1 (DM1).

Sblendorio brings three decades of biotech exit experience to Arthex's board

Sblendorio most recently led IVERIC bio, Inc. as CEO until its acquisition by Astellas Pharma, Inc. He previously served as President and Chief Financial Officer of The Medicines Company through its acquisition by Novartis, and as Executive Vice President and CFO of Eyetech Pharmaceuticals, Inc. until it was acquired by OSI Pharmaceuticals, Inc. Earlier in his career he was a Managing Director at MPM Capital Advisors.

Nel ASA Wins $12M Collins Aerospace Order for US Navy Submarine Oxygen Systems

Oslo, Norway – September 29, 2026 -- Nel ASA has secured a purchase order worth approximately USD 12 million from Collins Aerospace for PEM electrolyser stacks destined for US Navy submarine life-support systems. The order was placed through Nel Hydrogen US, a subsidiary of the Oslo-listed hydrogen technology company (OSE: NEL).

Collins Aerospace extends long-running defence procurement with Nel

The stacks will generate oxygen for submarine crews, an application where equipment failure carries direct safety consequences. Nel's Chief Commercial Officer, Todd Cartwright, said the order extends a long-standing cooperation with Collins Aerospace built around reliable oxygen generation for demanding submarine applications, and confirms the continued relevance of the company's PEM technology and manufacturing capabilities.

Leopard Imaging Debuts 8 AI Perception Cameras at VISION 2026

Image
Leopard Imaging Debuts 8 AI Perception Cameras at VISION 2026

Fremont, Calif. – September 29, 2026 -- Leopard Imaging will unveil eight new camera and AI perception platforms at VISION 2026, the machine vision trade show running October 6-8 in Stuttgart, Germany, at Hall 10, Booth 10G79.

Sirius Max combines Lumotive beam-steering with iToF depth sensing for long-range robotics perception

The compact RGB + depth platform supports programmable beam-steered illumination and embedded synchronization for software-defined 3D scanning in autonomous systems.

ASTRO Stereo Camera runs on NVIDIA Jetson Thor with dual 5.1MP global-shutter sensors

The system integrates IR projection, illumination, and NVIDIA Holoscan 10GigE connectivity to deliver synchronized RGB + IR stereo imaging, depth mapping, and 3D reconstruction for AI perception pipelines.

Arkestro's European Procurement Spend Hits $300M, Grows 93% Annually

Image
Arkestro's European Procurement Spend Hits $300M, Grows 93% Annually

Amsterdam – September 29, 2026 -- Nearly $300 million in European spend has now moved through Arkestro's predictive procurement platform, with regional volume growing 93% year over year, the company announced at DPW Amsterdam 2026.

Baseline spend in international procurement events surged 330% from 2024 to 2025

Arkestro projects a further 47% increase in 2026 as existing global customers extend the platform into additional European teams, categories and supplier networks. The company said the growth reflects enterprises seeking faster procurement decisions amid market volatility.

Platform users across Europe grew 78% year over year

Arkestro's buyer and supplier interactions now span 34 countries, and customers running completed European procurement events have generated approximately 10% average savings, the company said.